IPD datapackage for study 'A Phase 1, Randomized, Open-Label, Single-Dose, 2-Period Crossover Study to Assess the Relative Bioavailability of Two Formulation Strengths of TAK-875 and Metformin HCl (US Sourced Glucophage) When Administered as a Fixed-Dose Combination Tablet Compared With Individually Administered Tablets in Healthy Adult Subjects' included in Research Request: 'Stacy Data Provider approved 1'

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.